VIVIAN MUNDO: Open Payments
NPI 1043981533 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,003 in 121 payments from 28 companies in 2025. Trend: 2023 $1,533 · 2024 $2,139 · 2025 $2,003
Food & beverage: $2,003
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $335 |
| GlaxoSmithKline, LLC. | 12 | $213 |
| Novo Nordisk Inc | 11 | $166 |
| Lilly USA, LLC | 13 | $153 |
| PFIZER INC. | 7 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $140 |
| Inspire Medical Systems, Inc. | 3 | $81 |
| Astellas Pharma US Inc | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
Products named: TRELEGY ELLIPTA, Kerendia, QULIPTA, FARXIGA, MOUNJARO, NURTEC ODT, INSPIRE, Wegovy.
Industry payments across TX — which companies pay providers there.
